JP7324208B2 - 近視進行の治療 - Google Patents

近視進行の治療 Download PDF

Info

Publication number
JP7324208B2
JP7324208B2 JP2020537217A JP2020537217A JP7324208B2 JP 7324208 B2 JP7324208 B2 JP 7324208B2 JP 2020537217 A JP2020537217 A JP 2020537217A JP 2020537217 A JP2020537217 A JP 2020537217A JP 7324208 B2 JP7324208 B2 JP 7324208B2
Authority
JP
Japan
Prior art keywords
composition
copper
eye
ophthalmic
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020537217A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019136358A5 (enExample
JP2021509902A (ja
Inventor
マイケル バール、ランドン
アンバーティ、バラムラリ、ケイ．
エー． モロキア、サラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Utah Research Foundation Inc
Original Assignee
University of Utah Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Utah Research Foundation Inc filed Critical University of Utah Research Foundation Inc
Publication of JP2021509902A publication Critical patent/JP2021509902A/ja
Publication of JPWO2019136358A5 publication Critical patent/JPWO2019136358A5/ja
Priority to JP2023123138A priority Critical patent/JP7655988B2/ja
Application granted granted Critical
Publication of JP7324208B2 publication Critical patent/JP7324208B2/ja
Priority to JP2025046160A priority patent/JP2025111434A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2020537217A 2018-01-05 2019-01-07 近視進行の治療 Active JP7324208B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023123138A JP7655988B2 (ja) 2018-01-05 2023-07-28 近視進行の治療
JP2025046160A JP2025111434A (ja) 2018-01-05 2025-03-21 近視進行の治療

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862614230P 2018-01-05 2018-01-05
US62/614,230 2018-01-05
PCT/US2019/012501 WO2019136358A1 (en) 2018-01-05 2019-01-07 Treatment of myopic progression

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023123138A Division JP7655988B2 (ja) 2018-01-05 2023-07-28 近視進行の治療

Publications (3)

Publication Number Publication Date
JP2021509902A JP2021509902A (ja) 2021-04-08
JPWO2019136358A5 JPWO2019136358A5 (enExample) 2022-01-18
JP7324208B2 true JP7324208B2 (ja) 2023-08-09

Family

ID=67143996

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020537217A Active JP7324208B2 (ja) 2018-01-05 2019-01-07 近視進行の治療
JP2023123138A Active JP7655988B2 (ja) 2018-01-05 2023-07-28 近視進行の治療
JP2025046160A Pending JP2025111434A (ja) 2018-01-05 2025-03-21 近視進行の治療

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023123138A Active JP7655988B2 (ja) 2018-01-05 2023-07-28 近視進行の治療
JP2025046160A Pending JP2025111434A (ja) 2018-01-05 2025-03-21 近視進行の治療

Country Status (8)

Country Link
US (2) US11524032B2 (enExample)
EP (1) EP3735209A4 (enExample)
JP (3) JP7324208B2 (enExample)
KR (2) KR20250109788A (enExample)
CN (1) CN112105320A (enExample)
AU (2) AU2019205774B2 (enExample)
CA (1) CA3087622A1 (enExample)
WO (1) WO2019136358A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7655988B2 (ja) 2018-01-05 2025-04-02 ユニバーシティー オブ ユタ リサーチ ファウンデーション 近視進行の治療

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102771170B1 (ko) * 2016-03-08 2025-02-24 유니버시티 오브 유타 리서치 파운데이션 가교-결합제 및 관련 방법
US20220288114A1 (en) * 2019-07-11 2022-09-15 University Of Utah Research Foundation Multi-agent ocular formulations and treatment methods
TW202245810A (zh) * 2021-02-01 2022-12-01 美商艾維娜傳送系統公司 散光之治療
TW202302121A (zh) * 2021-02-11 2023-01-16 猶他大學研究基金會 近視之治療
CN115282349A (zh) * 2022-07-05 2022-11-04 复旦大学附属眼耳鼻喉科医院 一种有利于改善孟加拉玫瑰红-绿光角膜胶原交联技术中cct降低的角膜交联试剂
CN115386105B (zh) * 2022-08-26 2024-03-22 昆明理工大学 多重酶活性纳米酶荧光水凝胶的制备方法及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102985A (zh) 1993-11-23 1995-05-31 华中理工大学 一种防治近视的滴眼液
WO2017155580A1 (en) 2016-03-08 2017-09-14 University Of Utah Research Foundation Cross-linking agents and associated methods

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3416530A (en) * 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
WO1991004741A1 (fr) * 1989-09-27 1991-04-18 Moskovsky Nauchno-Issledovatelsky Institut Glaznykh Boleznei Imeni Gelmgoltsa Composition de traitement de la myopie evolutive
EP1159941A3 (en) * 1991-10-15 2003-09-17 Ista Pharmaceuticals, Inc. Formulations for use in enzyme-orthokeratology
WO1999045869A1 (en) * 1998-03-09 1999-09-16 Ista Pharmaceuticals, Inc. Use of corneal hardening agents in enzyme orthokeratology
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
CA2443244A1 (en) * 2001-04-13 2002-10-24 Incyte Genomics, Inc. Enzymes
WO2004058289A1 (en) * 2002-12-20 2004-07-15 Chakshu Research, Inc. Ophthalmic formulation for the prevention and treatment of ocular conditions
CN1518981A (zh) * 2003-07-23 2004-08-11 复旦大学附属眼耳鼻喉科医院 一种治疗近视的外用滴眼制剂
MXPA03011987A (es) * 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
EP1814540A2 (en) 2004-11-16 2007-08-08 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
US20060276777A1 (en) * 2005-04-08 2006-12-07 Coroneo Minas T Corneal shaping
US20080014278A1 (en) 2006-06-30 2008-01-17 Nucryst Pharmaceuticals Metal-containing formulations and methods of use
US20140343480A1 (en) * 2013-05-19 2014-11-20 Avedro, Inc. Systems, methods, and compositions for cross-linking
RU2635185C2 (ru) * 2013-12-17 2017-11-09 Иван Дмитриевич Захаров Фармацевтический препарат для профилактики и лечения прогрессирующей близорукости
BR112016023453A2 (pt) * 2014-04-09 2021-06-01 Peter Iseli Hans dispositivo para um tratamento médico de uma esclera
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
CN107530324A (zh) * 2015-04-09 2018-01-02 雷伯瑞特里巴达西公司 用于眼科用途的吡咯烷酮羧酸（pca）
US10010502B2 (en) 2015-05-19 2018-07-03 Amorphex Therapeutics Llc Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
MX2020005217A (es) 2017-11-21 2020-11-24 Sydnexis Inc Composicion oftalmica y dispositivo de administracion de la misma.
KR20250109788A (ko) * 2018-01-05 2025-07-17 유니버시티 오브 유타 리서치 파운데이션 근시 진행의 치료
US20220288114A1 (en) * 2019-07-11 2022-09-15 University Of Utah Research Foundation Multi-agent ocular formulations and treatment methods
TW202245810A (zh) * 2021-02-01 2022-12-01 美商艾維娜傳送系統公司 散光之治療
TW202302121A (zh) * 2021-02-11 2023-01-16 猶他大學研究基金會 近視之治療

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102985A (zh) 1993-11-23 1995-05-31 华中理工大学 一种防治近视的滴眼液
WO2017155580A1 (en) 2016-03-08 2017-09-14 University Of Utah Research Foundation Cross-linking agents and associated methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Current Eye Research，2018年，Vol.43, No.2，pp.200-207，Published online: 14 Nov 2017
J Cataract Refract Surg，2004年，Vol.30，pp.689-695

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7655988B2 (ja) 2018-01-05 2025-04-02 ユニバーシティー オブ ユタ リサーチ ファウンデーション 近視進行の治療

Also Published As

Publication number Publication date
EP3735209A4 (en) 2021-09-08
AU2019205774A1 (en) 2020-08-06
AU2024278182A1 (en) 2025-01-02
AU2019205774B2 (en) 2025-01-02
JP7655988B2 (ja) 2025-04-02
JP2021509902A (ja) 2021-04-08
US11524032B2 (en) 2022-12-13
CN112105320A (zh) 2020-12-18
EP3735209A1 (en) 2020-11-11
KR102831250B1 (ko) 2025-07-08
KR20200118426A (ko) 2020-10-15
US20230256012A1 (en) 2023-08-17
WO2019136358A1 (en) 2019-07-11
CA3087622A1 (en) 2019-07-11
JP2025111434A (ja) 2025-07-30
JP2023153905A (ja) 2023-10-18
KR20250109788A (ko) 2025-07-17
US20210060059A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
JP7655988B2 (ja) 近視進行の治療
AU2023202236B2 (en) Cross-linking agents and associated methods
AU2020311441B2 (en) Multi-agent ocular formulations and treatment methods
US20240122974A1 (en) Treatment of myopia
HK40107891A (en) Cross-linking agents and associated methods

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220107

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220107

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20221019

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221025

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230124

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230425

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230704

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230728

R150 Certificate of patent or registration of utility model

Ref document number: 7324208

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150